Postoperative radiotherapy for patients with oral squamous cell carcinoma with intermediate risk of recurrence: A case match study

The purpose of this study was to determine the effect of postoperative radiotherapy (PORT) on recurrence and survival in patients with oral squamous cell carcinoma (OSCC) of intermediate recurrence risk.

[1]  Jonathan R. Clark,et al.  Concurrent chemoradiotherapy compared with surgery and adjuvant radiotherapy for oral cavity squamous cell carcinoma , 2015, Head & neck.

[2]  James S. Brown,et al.  Post Operative Radiotherapy For Patients With Oral Squamous Cell Carcinoma With Intermediate Risk Of Recurrence: A Case Match Study , 2014 .

[3]  Jonathan R. Clark,et al.  Prospective quality of life assessment between treatment groups for oral cavity squamous cell carcinoma , 2014, Head & neck.

[4]  J. Ringash,et al.  Health related quality of life in head and neck cancer treated with radiation therapy with or without chemotherapy: a systematic review. , 2013, Oral oncology.

[5]  S. Rogers,et al.  Systematic review of the current evidence in the use of postoperative radiotherapy for oral squamous cell carcinoma. , 2012, The British journal of oral & maxillofacial surgery.

[6]  R. Gilbert,et al.  Squamous cell carcinoma of the buccal mucosa: Outcomes of Treatment in the modern era , 2012, The Laryngoscope.

[7]  S. Rogers,et al.  Adjuvant radiotherapy and health-related quality of life of patients at intermediate risk of recurrence following primary surgery for oral squamous cell carcinoma. , 2011, Oral oncology.

[8]  M. Shrime,et al.  The impact of adjuvant radiotherapy on survival in T1-2N1 squamous cell carcinoma of the oral cavity. , 2010, Archives of otolaryngology--head & neck surgery.

[9]  Johannes A Langendijk,et al.  Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. , 2009, International journal of radiation oncology, biology, physics.

[10]  S. Rogers,et al.  A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with post-operative radiotherapy. , 2007, Oral oncology.

[11]  James S. Brown,et al.  A questionnaire survey of current UK practice for adjuvant radiotherapy following surgery for oral and oropharyngeal squamous cell carcinoma. , 2007, Oral oncology.

[12]  Yaoh-Shiang Lin,et al.  Squamous cell carcinoma of the buccal mucosa: An aggressive cancer requiring multimodality treatment , 2006, Head & neck.

[13]  S. Dixit,et al.  Surgery versus surgery and postoperative radiotherapy in squamous cell carcinoma of the buccal mucosa: A comparative study , 1998, Annals of Surgical Oncology.

[14]  R. C. Mishra,et al.  Post-operative radiotherapy in carcinoma of buccal mucosa, a prospective randomized trial. , 1996, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  J. Beatty,et al.  Postoperative radiation as adjuvant treatment for carcinoma of the oral cavity larynx, and pharynx: Preliminary report of a prospective randomized trial , 1988, Journal of surgical oncology.

[16]  Fletcher Gh,et al.  Planned combination of surgery and radiation in treatment of advanced primary head and neck cancers. , 1957 .

[17]  Sarah J. Johnson,et al.  Standards and datasets for reporting cancers , 2013 .

[18]  J. Rodrigo,et al.  [Efficacy of postoperative radiation therapy for squamous cell carcinoma of the head and neck: results of a prospective randomised clinical trial]. , 2004, Acta Otorrinolaringológica Española.

[19]  J. Rodrigo,et al.  Eficacia de la radioterapia postoperatoria en los carcinomas epidermoides de cabeza y cuello: resultados de un ensayo prospectivo aleatorizado , 2004 .

[20]  G. Fletcher,et al.  Planned combination of surgery and radiation in treatment of advanced primary head and neck cancers. , 1957, The American journal of roentgenology, radium therapy, and nuclear medicine.